Skip to Content

EC 35 (Risedronate Sodium Delayed-Release 35 mg)

Pill with imprint EC 35 is Yellow, Capsule-shape and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Actavis.

Risedronate is used in the treatment of osteoporosis; paget's disease; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EC 35

Risedronate Sodium Delayed-Release

Imprint:
EC 35
Strength:
35 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis
National Drug Code (NDC):
00591-3876

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide